| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Revankar Shriram | SVP, Advanced Technology Group | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO | /s/ Daniel Rodriguez as Attorney-in-Fact for Shriram Revankar | 26 Aug 2025 | 0001928994 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DLB | Class A Common Stock | Sale | -$524K | -7K | -9.04% | $74.92 | 70.4K | 22 Aug 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares held following the reported transactions include 47,766 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |